Proteome Sciences (LON:PRM) Trading Down 9.9%

Shares of Proteome Sciences plc (LON:PRM) traded down 9.9% on Tuesday . The stock traded as low as GBX 3.56 ($0.05) and last traded at GBX 3.56 ($0.05). 250,000 shares were traded during mid-day trading, an increase of 38% from the average session volume of 180,813 shares. The stock had previously closed at GBX 3.95 ($0.05).

Proteome Sciences Price Performance

The business’s 50-day moving average price is GBX 3.78 and its 200-day moving average price is GBX 4.01. The firm has a market capitalization of £11.07 million, a PE ratio of -375.00 and a beta of -0.03.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.